| Prevalence of cervical cancer screening among women aged 30-49 years (%) WHO | WHO | – |
| Crude suicide rates (per 100 000 population) WHO | WHO | – |
| Age-standardized suicide rates (per 100 000 population) WHO | WHO | −1.5% |
| Mortality rate attributed to unintentional poisoning (per 100 000 population) WHO | WHO | −16.7% |
| Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths WHO | WHO | −3.7% |
| Age-standardized NCD mortality rate (per 100 000 population) WHO | WHO | −4.8% |
| Total NCD Deaths WHO | WHO | −8.2% |
| Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease WHO | WHO | −6.5% |
| Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) WHO | WHO | −11.8% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4, female (% of female population ages 0-4) Gender Statistics | Gender Statistics | −0.4% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4, male (% of male population ages 0-4) Gender Statistics | Gender Statistics | −0.5% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 0-4 (% of population ages 0-4) Gender Statistics | Gender Statistics | −0.5% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14, female (% of female population ages 5-14) Gender Statistics | Gender Statistics | −2.9% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14, male (% of male population ages 5-14) Gender Statistics | Gender Statistics | −3.1% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 5-14 (% of population ages 5-14) Gender Statistics | Gender Statistics | −3% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59, female (% of female population ages 15-59) Gender Statistics | Gender Statistics | −2.7% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59, male (% of male population ages 15-59) Gender Statistics | Gender Statistics | +1.8% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 15-59 (% of population ages 15-59) Gender Statistics | Gender Statistics | −0.2% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+, female (% of female population ages 60+) Gender Statistics | Gender Statistics | +7.1% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+, male (% of male population ages 60+) Gender Statistics | Gender Statistics | +11.1% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, ages 60+ (% of population ages 60+) Gender Statistics | Gender Statistics | +9.2% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, female (% of female population) Gender Statistics | Gender Statistics | −1.9% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions, male (% of male population) Gender Statistics | Gender Statistics | +1% |
| Cause of death, by injury, ages 0-4, female (% of female population ages 0-4) Gender Statistics | Gender Statistics | +5% |
| Cause of death, by injury, ages 0-4, male (% of male population ages 0-4) Gender Statistics | Gender Statistics | +6% |
| Cause of death, by injury, ages 0-4 (% of population ages 0-4) Gender Statistics | Gender Statistics | +5.6% |
| Cause of death, by injury, ages 5-14, female (% of female population ages 5-14) Gender Statistics | Gender Statistics | +8% |
| Cause of death, by injury, ages 5-14, male (% of male population ages 5-14) Gender Statistics | Gender Statistics | +5.4% |
| Cause of death, by injury, ages 5-14 (% of population ages 5-14) Gender Statistics | Gender Statistics | +6.5% |
| Cause of death, by injury, ages 15-59, female (% of female population ages 15-59) Gender Statistics | Gender Statistics | +3.5% |
| Cause of death, by injury, ages 15-59, male (% of male population ages 15-59) Gender Statistics | Gender Statistics | +1.3% |
| Cause of death, by injury, ages 15-59 (% of population ages 15-59) Gender Statistics | Gender Statistics | +1.5% |
| Cause of death, by injury, ages 60+, female (% of female population ages 60+) Gender Statistics | Gender Statistics | −1.2% |
| Cause of death, by injury, ages 60+, male (% of male population ages 60+) Gender Statistics | Gender Statistics | −3.4% |
| Cause of death, by injury, ages 60+ (% of population ages 60+) Gender Statistics | Gender Statistics | −3.2% |
| Cause of death, by injury, female (% of female population) Gender Statistics | Gender Statistics | +3.6% |
| Cause of death, by injury, male (% of male population) Gender Statistics | Gender Statistics | +3.3% |
| Cause of death, by non-communicable diseases, ages 0-4, female (% of female population ages 0-4) Gender Statistics | Gender Statistics | +1.3% |
| Cause of death, by non-communicable diseases, ages 0-4, male (% of male population ages 0-4) Gender Statistics | Gender Statistics | +1.2% |
| Cause of death, by non-communicable diseases, ages 0-4 (% of population ages 0-4) Gender Statistics | Gender Statistics | +1.2% |
| Cause of death, by non-communicable diseases, ages 5-14, female (% of female population ages 5-14) Gender Statistics | Gender Statistics | −0.4% |
| Cause of death, by non-communicable diseases, ages 5-14, male (% of male population ages 5-14) Gender Statistics | Gender Statistics | −0.9% |
| Cause of death, by non-communicable diseases, ages 5-14 (% of population ages 5-14) Gender Statistics | Gender Statistics | −0.7% |
| Cause of death, by non-communicable diseases, ages 15-59, female (% of female population ages 15-59) Gender Statistics | Gender Statistics | −0.1% |
| Cause of death, by non-communicable diseases, ages 15-59, male (% of male population ages 15-59) Gender Statistics | Gender Statistics | −3.9% |
| Cause of death, by non-communicable diseases, ages 15-59 (% of population ages 15-59) Gender Statistics | Gender Statistics | −2.3% |
| Cause of death, by non-communicable diseases, ages 60+, female (% of female population ages 60+) Gender Statistics | Gender Statistics | −3.5% |
| Cause of death, by non-communicable diseases, ages 60+, male (% of male population ages 60+) Gender Statistics | Gender Statistics | −5.8% |
| Cause of death, by non-communicable diseases, ages 60+ (% of population ages 60+) Gender Statistics | Gender Statistics | −4.6% |
| Cause of death, by non-communicable diseases, female (% of female population) Gender Statistics | Gender Statistics | +0.1% |
| Cause of death, by non-communicable diseases, male (% of male population) Gender Statistics | Gender Statistics | −4.1% |
| Access to anti-retroviral drugs, female (%) Gender Statistics | Gender Statistics | +2.1% |
| Access to anti-retroviral drugs, male (%) Gender Statistics | Gender Statistics | +10.3% |
| Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49) Gender Statistics | Gender Statistics | −3.7% |
| Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49) Gender Statistics | Gender Statistics | −5% |
| Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24) Gender Statistics | Gender Statistics | −3.2% |
| Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24) Gender Statistics | Gender Statistics | 0% |
| Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, female (per 100,000 female population) Gender Statistics | Gender Statistics | – |
| Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, male (per 100,000 male population) Gender Statistics | Gender Statistics | – |
| Total alcohol consumption per capita, female (liters of pure alcohol, projected estimates, female 15+ years of age) World Development Indicators | World Development Indicators | +1.9% |
| Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age) World Development Indicators | World Development Indicators | +1.4% |
| Total alcohol consumption per capita, male (liters of pure alcohol, projected estimates, male 15+ years of age) World Development Indicators | World Development Indicators | +1.7% |
| Prevalence of anemia among women of reproductive age (% of women ages 15-49) World Development Indicators | World Development Indicators | +1.2% |
| Prevalence of anemia among children (% of children ages 6-59 months) World Development Indicators | World Development Indicators | −0.5% |
| Prevalence of anemia among non-pregnant women (% of women ages 15-49) World Development Indicators | World Development Indicators | +1.3% |
| Condom use, population ages 15-24, female (% of females ages 15-24) World Development Indicators | World Development Indicators | +102.3% |
| Condom use, population ages 15-24, male (% of males ages 15-24) World Development Indicators | World Development Indicators | +44.8% |
| Number of deaths ages 5-9 years World Development Indicators | World Development Indicators | −2.2% |
| Number of deaths ages 10-14 years World Development Indicators | World Development Indicators | −1.1% |
| Number of deaths ages 15-19 years World Development Indicators | World Development Indicators | −0.1% |
| Number of deaths ages 20-24 years World Development Indicators | World Development Indicators | +0.9% |
| Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total) World Development Indicators | World Development Indicators | −0.3% |
| Number of infant deaths World Development Indicators | World Development Indicators | −2% |
| Cause of death, by injury (% of total) World Development Indicators | World Development Indicators | +3.1% |
| Number of under-five deaths World Development Indicators | World Development Indicators | −2.4% |
| Cause of death, by non-communicable diseases (% of total) World Development Indicators | World Development Indicators | −2.2% |
| Number of neonatal deaths World Development Indicators | World Development Indicators | −0.9% |
| Probability of dying among children ages 5-9 years (per 1,000) World Development Indicators | World Development Indicators | −3.4% |
| Probability of dying among adolescents ages 10-14 years (per 1,000) World Development Indicators | World Development Indicators | −4.1% |
| Probability of dying among adolescents ages 15-19 years (per 1,000) World Development Indicators | World Development Indicators | −3% |
| Probability of dying among youth ages 20-24 years (per 1,000) World Development Indicators | World Development Indicators | −1.1% |
| Women's share of population ages 15+ living with HIV (%) World Development Indicators | World Development Indicators | +0.2% |
| Prevalence of HIV, total (% of population ages 15-49) World Development Indicators | World Development Indicators | −5.9% |
| Mortality rate, under-5 (per 1,000 live births) World Development Indicators | World Development Indicators | −3.4% |
| Mortality rate, under-5, female (per 1,000 live births) World Development Indicators | World Development Indicators | −3.2% |
| Mortality rate, under-5, male (per 1,000 live births) World Development Indicators | World Development Indicators | −3.2% |
| Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%) World Development Indicators | World Development Indicators | −0.4% |
| Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) World Development Indicators | World Development Indicators | −6.7% |
| Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%) World Development Indicators | World Development Indicators | −3.8% |
| Mortality rate, neonatal (per 1,000 live births) World Development Indicators | World Development Indicators | −1.7% |
| Demand for family planning satisfied by modern methods (% of married women with demand for family planning) World Development Indicators | World Development Indicators | +171.4% |
| People using safely managed drinking water services, rural (% of rural population) World Development Indicators | World Development Indicators | +2.6% |
| People using safely managed drinking water services, urban (% of urban population) World Development Indicators | World Development Indicators | +0.3% |
| People using safely managed drinking water services (% of population) World Development Indicators | World Development Indicators | +1.6% |
| Prevalence of HIV, female (% ages 15-24) World Development Indicators | World Development Indicators | 0% |
| Prevalence of HIV, male (% ages 15-24) World Development Indicators | World Development Indicators | 0% |
| Antiretroviral therapy coverage (% of people living with HIV) World Development Indicators | World Development Indicators | +5.7% |
| Incidence of HIV, all (per 1,000 uninfected population) World Development Indicators | World Development Indicators | −5.1% |
| Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24) World Development Indicators | World Development Indicators | −3.4% |
| Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49) World Development Indicators | World Development Indicators | −3.3% |
| Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) World Development Indicators | World Development Indicators | −1.1% |
| Immunization, HepB3 (% of one-year-old children) World Development Indicators | World Development Indicators | 0% |
| Immunization, DPT (% of children ages 12-23 months) World Development Indicators | World Development Indicators | 0% |
| Immunization, measles (% of children ages 12-23 months) World Development Indicators | World Development Indicators | 0% |
| Hospital beds (per 1,000 people) World Development Indicators | World Development Indicators | −19.5% |
| Nurses and midwives (per 1,000 people) World Development Indicators | World Development Indicators | +28% |
| Physicians (per 1,000 people) World Development Indicators | World Development Indicators | +40.4% |
| Specialist surgical workforce (per 100,000 population) World Development Indicators | World Development Indicators | – |
| Incidence of malaria (per 1,000 population at risk) World Development Indicators | World Development Indicators | −5.9% |
| Use of insecticide-treated bed nets (% of under-5 population) World Development Indicators | World Development Indicators | +62.9% |
| Children with fever receiving antimalarial drugs (% of children under age 5 with fever) World Development Indicators | World Development Indicators | +69.9% |
| Number of maternal deaths World Development Indicators | World Development Indicators | 0% |
| Lifetime risk of maternal death (1 in: rate varies by country) World Development Indicators | World Development Indicators | +5.8% |
| Lifetime risk of maternal death (%) World Development Indicators | World Development Indicators | −5.1% |
| Prevalence of anemia among pregnant women (%) World Development Indicators | World Development Indicators | +0.2% |
| Prevalence of current tobacco use (% of adults) World Development Indicators | World Development Indicators | −4.9% |
| Prevalence of current tobacco use, females (% of female adults) World Development Indicators | World Development Indicators | 0% |
| Prevalence of current tobacco use, males (% of male adults) World Development Indicators | World Development Indicators | −3.6% |
| Mortality rate attributed to household and ambient air pollution, age-standardized, female (per 100,000 female population) World Development Indicators | World Development Indicators | – |
| Mortality rate attributed to household and ambient air pollution, age-standardized, male (per 100,000 male population) World Development Indicators | World Development Indicators | – |
| Mortality rate attributed to household and ambient air pollution, age-standardized (per 100,000 population) World Development Indicators | World Development Indicators | – |
| Pregnant women receiving prenatal care (%) World Development Indicators | World Development Indicators | +7.2% |
| ARI treatment (% of children under 5 taken to a health provider) World Development Indicators | World Development Indicators | −19.6% |
| Exclusive breastfeeding (% of children under 6 months) World Development Indicators | World Development Indicators | +12.5% |
| Births attended by skilled health staff (% of total) World Development Indicators | World Development Indicators | +55.6% |
| Low-birthweight babies (% of births) World Development Indicators | World Development Indicators | −0.5% |
| Diabetes prevalence (% of population ages 20 to 79) World Development Indicators | World Development Indicators | +45.5% |
| Prevalence of underweight, weight for age (% of children under 5) World Development Indicators | World Development Indicators | −5.6% |
| Maternal mortality ratio (modeled estimate, per 100,000 live births) World Development Indicators | World Development Indicators | −3.6% |
| Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding) World Development Indicators | World Development Indicators | −24.9% |
| Diarrhea treatment (% of children under 5 who received ORS packet) World Development Indicators | World Development Indicators | −26.5% |
| Prevalence of overweight, weight for height, female (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +17.9% |
| Prevalence of overweight, weight for height, male (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +15.2% |
| Prevalence of overweight, weight for height (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | +20% |
| Mortality rate attributed to unintentional poisoning (per 100,000 population) World Development Indicators | World Development Indicators | −1.8% |
| Mortality rate attributed to unintentional poisoning, female (per 100,000 female population) World Development Indicators | World Development Indicators | 0% |
| Mortality rate attributed to unintentional poisoning, male (per 100,000 male population) World Development Indicators | World Development Indicators | −2.6% |
| People using safely managed sanitation services, rural (% of rural population) World Development Indicators | World Development Indicators | 0% |
| People using safely managed sanitation services, urban (% of urban population) World Development Indicators | World Development Indicators | 0% |
| People using safely managed sanitation services (% of population) World Development Indicators | World Development Indicators | +0.2% |
| Prevalence of stunting, height for age, female (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | −0.5% |
| Prevalence of stunting, height for age, male (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | −0.4% |
| Prevalence of stunting, height for age (modeled estimate, % of children under 5) World Development Indicators | World Development Indicators | −0.4% |
| Suicide mortality rate, female (per 100,000 female population) World Development Indicators | World Development Indicators | +3.7% |
| Suicide mortality rate, male (per 100,000 male population) World Development Indicators | World Development Indicators | −1.4% |
| Suicide mortality rate (per 100,000 population) World Development Indicators | World Development Indicators | −0.4% |
| Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (per 100,000 population) World Development Indicators | World Development Indicators | – |
| Prevalence of wasting, weight for height (% of children under 5) World Development Indicators | World Development Indicators | −13.6% |
| Prevalence of severe wasting, weight for height (% of children under 5) World Development Indicators | World Development Indicators | −26.7% |
| Tuberculosis treatment success rate (% of new cases) World Development Indicators | World Development Indicators | −1.2% |
| Tuberculosis case detection rate (%, all forms) World Development Indicators | World Development Indicators | −2.8% |
| Incidence of tuberculosis (per 100,000 people) World Development Indicators | World Development Indicators | +2.1% |
| Newborns protected against tetanus (%) World Development Indicators | World Development Indicators | 0% |
| Current health expenditure (% of GDP) World Development Indicators | World Development Indicators | −2.1% |
| Current health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +6.8% |
| Current health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +4.9% |
| External health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | −3.3% |
| External health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +3.3% |
| External health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +1.5% |
| Domestic general government health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | +4.5% |
| Domestic general government health expenditure (% of GDP) World Development Indicators | World Development Indicators | +2.3% |
| Domestic general government health expenditure (% of general government expenditure) World Development Indicators | World Development Indicators | 0% |
| Domestic general government health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +11.6% |
| Domestic general government health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +9.6% |
| Out-of-pocket expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | +0.3% |
| Out-of-pocket expenditure per capita (current US$) World Development Indicators | World Development Indicators | +7.1% |
| Out-of-pocket expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +5.2% |
| Domestic private health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | +0.3% |
| Domestic private health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +7.1% |
| Domestic private health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +5.2% |
| Prevalence of undernourishment (% of population) World Development Indicators | World Development Indicators | −9.7% |
| Consumption of iodized salt (% of households) World Development Indicators | World Development Indicators | +4.4% |
| Vitamin A supplementation coverage rate (% of children ages 6-59 months) World Development Indicators | World Development Indicators | −73.3% |
| Mortality rate, adult, female (per 1,000 female adults) World Development Indicators | World Development Indicators | −1.1% |
| Mortality rate, adult, male (per 1,000 male adults) World Development Indicators | World Development Indicators | −0.7% |
| Contraceptive prevalence, any modern method (% of married women ages 15-49) World Development Indicators | World Development Indicators | +23.7% |
| Contraceptive prevalence, any method (% of married women ages 15-49) World Development Indicators | World Development Indicators | +19.6% |
| Mortality rate, infant, female (per 1,000 live births) World Development Indicators | World Development Indicators | −2.8% |
| Mortality rate, infant (per 1,000 live births) World Development Indicators | World Development Indicators | −3.1% |
| Mortality rate, infant, male (per 1,000 live births) World Development Indicators | World Development Indicators | −3% |
| Life expectancy at birth, female (years) World Development Indicators | World Development Indicators | +0.4% |
| Life expectancy at birth, total (years) World Development Indicators | World Development Indicators | +0.3% |
| Life expectancy at birth, male (years) World Development Indicators | World Development Indicators | +0.3% |
| Survival to age 65, female (% of cohort) World Development Indicators | World Development Indicators | +0.6% |
| Survival to age 65, male (% of cohort) World Development Indicators | World Development Indicators | +0.4% |
| Population ages 75-79, female (% of female population) World Development Indicators | World Development Indicators | −4.1% |
| Population ages 75-79, male (% of male population) World Development Indicators | World Development Indicators | −1.8% |
| Population ages 80 and above, female (% of female population) World Development Indicators | World Development Indicators | −8% |
| Population ages 80 and above, male (% of male population) World Development Indicators | World Development Indicators | −7.6% |
| Completeness of birth registration (%) World Development Indicators | World Development Indicators | +6.3% |
| Unmet need for contraception (% of married women ages 15-49) World Development Indicators | World Development Indicators | +1.2% |
| Number of female leprosy new cases WHO | WHO | −13.9% |
| New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population WHO | WHO | −50.7% |
| Number of non-autochthonous leprosy cases WHO | WHO | 0 |
| New leprosy case detection rate per 1 000 000 population WHO | WHO | −19.3% |
| Leprosy - Number of cases registered for treatment WHO | WHO | −21.3% |
| Leprosy registered prevalence rate per 1 000 000 population WHO | WHO | −22.9% |
| Number of new G2D leprosy cases WHO | WHO | +32.1% |
| Leprosy - New leprosy cases with G2D rate per 1 000 000 population WHO | WHO | +29.3% |
| Leprosy - Number of new leprosy cases among children (less than 15 years of age) WHO | WHO | −50% |
| Number of new leprosy cases with G2D among children (less than 15 years of age) WHO | WHO | +1 |
| Number of new leprosy cases WHO | WHO | −17.6% |
| Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis WHO | WHO | +8.2% |
| Reported number of individuals treated for onchocerciasis WHO | WHO | −73.1% |
| New chronic hepatitis B (HBV) infections (number) WHO | WHO | −30.7% |
| Hepatitis - Deaths caused by chronic hepatitis B and C (per 100 000 population) WHO | WHO | +2.6% |
| People living with chronic hepatitis B (HBV) (number) WHO | WHO | −4.2% |
| Prevalence of chronic hepatitis B (HBV) in the general population (%) WHO | WHO | −22.9% |
| New chronic hepatitis C (HCV) infections (number) WHO | WHO | −10.6% |
| People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number) WHO | WHO | +20.3% |
| People living with chronic hepatitis C (HCV) (number) WHO | WHO | +2.8% |
| Prevalence of chronic hepatitis C (HCV) ) in the general population (%) WHO | WHO | −16.5% |
| Hepatitis - Deaths caused by chronic hepatitis B and C WHO | WHO | +27.4% |
| Persons on chronic hepatitis B (HBV) treatment (number) WHO | WHO | +183.7% |
| Chronic hepatitis B (HBV) treatment rate as percentage of diagnosed (%) WHO | WHO | −20.2% |
| Chronic hepatitis B (HBV) treatment rate as percentage of total infected (%) WHO | WHO | +150% |
| Persons on chronic hepatitis C (HCV) treatment, cumulative (number) WHO | WHO | +3,693.1% |
| Chronic hepatitis C (HCV) cumulative treatment rate as percentage of total infected, including cured (%) WHO | WHO | +3,075% |
| Persons initiated chronic hepatitis C(HCV) treatment (number) WHO | WHO | +444.8% |
| Chronic hepatitis C (HCV) treatment rate as percentage of diagnosed (%) WHO | WHO | +2,474.6% |
| Chronic hepatitis B (HBV) infected persons diagnosed (number) WHO | WHO | +255.1% |
| Chronic hepatitis B (HBV) diagnosis coverage as a percentage of infected (%) WHO | WHO | +269.4% |
| Chronic hepatitis C (HCV) infected persons diagnosed, including cured (number) WHO | WHO | +48.1% |
| Chronic hepatitis C (HCV) infected persons diagnosed (number) WHO | WHO | +1% |
| Chronic hepatitis C (HCV) diagnosis coverage as percentage of total HCV infected, including cured (%) WHO | WHO | +23% |
| Pregnant women attending antenatal care, tested for HBsAg (percent) WHO | WHO | – |
| Pregnant women attending antenatal care, tested positive for HBsAg (percent) WHO | WHO | – |
| Life expectancy at birth (years) WHO | WHO | +2.7% |
| Healthy life expectancy (HALE) at birth (years) WHO | WHO | +2.9% |
| Healthy life expectancy (HALE) at age 60 (years) WHO | WHO | +4.6% |
| Life expectancy at age 60 (years) WHO | WHO | +3.7% |
| Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) WHO | WHO | +1.4% |
| Physical activity policies for activie societies WHO | WHO | 0 |
| Physical activity policies focused on active systems WHO | WHO | 0% |
| Overweight numbers among children under 5 years of age (thousands), model-based estimates WHO | WHO | +19.5% |
| Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates WHO | WHO | +17.9% |
| Stunting numbers among children under 5 years of age (millions), model-based estimates WHO | WHO | +0.6% |
| Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates WHO | WHO | −0.4% |
| Number of under-five deaths WHO | WHO | −2.4% |
| Under-five mortality rate (probability of dying by age 5 per 1000 live births) WHO | WHO | −3.6% |
| Stillbirth rate (per 1000 total births) WHO | WHO | −1% |
| Number of deaths among children ages 5 to 9 years WHO | WHO | −3% |
| Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) WHO | WHO | −3.6% |
| Number of neonatal deaths WHO | WHO | −0.9% |
| Neonatal mortality rate (per 1000 live births) WHO | WHO | −1.7% |
| Number of deaths among children 5 to 14 years of age WHO | WHO | −1.7% |
| Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) WHO | WHO | −3% |
| Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) WHO | WHO | +3.8% |
| Number of infant deaths WHO | WHO | −2% |
| Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) WHO | WHO | −3.1% |
| Number of deaths among adolescents (10 to 19 years of age) WHO | WHO | −1.1% |
| Adolescent mortality rate (per 1 000 age specific cohort) WHO | WHO | −4.1% |
| Hepatitis B surface antigen (HBsAg) prevalence (%) WHO | WHO | −2.9% |
| Estimated number of people (all ages) living with HIV WHO | WHO | 0% |
| Number of people dying from HIV-related causes WHO | WHO | −15% |
| Reported number of people receiving antiretroviral therapy WHO | WHO | +1.2% |
| Reported number of children receiving antiretroviral therapy WHO | WHO | −5.1% |
| Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission WHO | WHO | +9.8% |
| Estimated number of pregnant women living with HIV WHO | WHO | +15.2% |
| Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission WHO | WHO | −4.7% |
| Estimated number of children needing antiretroviral therapy based on WHO methods WHO | WHO | −6.7% |
| Estimated antiretroviral therapy coverage among children WHO | WHO | 0% |
| Number of new HIV infections WHO | WHO | −16% |
| Estimated antiretroviral therapy coverage among people living with HIV (%) WHO | WHO | +2.2% |
| Prevalence of HIV among adults aged 15 to 49 (%) WHO | WHO | −5.9% |
| New HIV infections (per 1000 uninfected population) WHO | WHO | −16.2% |
| Childhood cancer survival for lymphoid leukaemia, age-standardized 5-year net survival (%) WHO | WHO | – |
| International Health Regulations core capacity scores, SPAR version, 2nd edition WHO | WHO | +8.3% |
| Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem WHO | WHO | 0 |
| Number of people who received treatment with antibiotics for trachoma WHO | WHO | 0 |
| Reported number of human rabies deaths WHO | WHO | – |
| Number of people operated for trachomatous trichiasis WHO | WHO | −87.5% |
| HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%) WHO | WHO | −20% |
| Polio (Pol3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Pertussis - number of reported cases WHO | WHO | 0 |
| Total tetanus - number of reported cases WHO | WHO | −20% |
| Yellow fever - number of reported cases WHO | WHO | +100% |
| Rubella - number of reported cases WHO | WHO | −34.8% |
| Diphtheria - number of reported cases WHO | WHO | 0 |
| Congenital Rubella Syndrome - number of reported cases WHO | WHO | 0% |
| Neonatal tetanus - number of reported cases WHO | WHO | −20% |
| Measles - number of reported cases WHO | WHO | +162.9% |
| Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) WHO | WHO | 0% |
| Yellow fever vaccine (YFV) immunization coverage among 1-year olds (%) WHO | WHO | 0% |
| Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) WHO | WHO | 0% |
| Hib (Hib3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Inactivated first-dose polio vaccine (IPV1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | 0% |
| Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| BCG immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | 0% |
| Adopted written national policy on alcohol WHO | WHO | 0 |
| Alcoholic beverage legally defined WHO | WHO | 0 |
| National legislation to prevent illegal alcohol WHO | WHO | 0 |
| Standard drink defined WHO | WHO | 0 |
| National drinking guidelines WHO | WHO | 0 |
| National legislation to prevent illegal alcohol sales WHO | WHO | 0 |